A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.
about
Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer CellsThe YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.SOXC proteins amplify canonical WNT signaling to secure nonchondrocytic fates in skeletogenesis.Tocotrienol-rich fraction (TRF) suppresses the growth of human colon cancer xenografts in Balb/C nude mice by the Wnt pathwayMetastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.Functional screen identifies kinases driving prostate cancer visceral and bone metastasis.DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases.Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathwayDDX3 enhances oncogenic KRAS‑induced tumor invasion in colorectal cancer via the β‑catenin/ZEB1 axis.TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling.Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.SOX12: a novel potential target for acute myeloid leukaemia.Commentary: HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition.SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.Mouse models in the era of large human tumour sequencing studies
P2860
Q28555025-BF884874-D850-4FDE-A742-C28BFDD9E1B4Q33588163-FE563333-34FF-429D-98BA-2070CC43BD96Q34656830-55BD1482-3564-42BD-B066-92CBD0EFB6BEQ35217455-467E0A21-5252-4EF5-9C5D-D6B3F729BD36Q35944921-A1CBBEF6-7C96-4EB2-87E0-C9AAD59CCC50Q36307011-A9A87410-782F-4150-A189-7C558EA43DECQ36483279-C6A61D7E-E36F-4500-8183-1E196D46E5B6Q36595592-691FD2B9-FF64-4ED4-8765-69A80D4B0F71Q36751660-584834C2-2D0A-481A-BF74-40B3984F64ACQ36893292-40EDBA5A-4CB2-4885-B0CF-02C3E56B7214Q37225645-CDBE663E-ED94-430B-9F73-D26722355648Q37453813-FDB69592-8663-4708-A9C7-2C23B87C5FDEQ38630243-E1BDFD43-C72E-4087-8BBA-3D463414C6E3Q38730529-E7B69876-A8E1-45B4-B01F-0D59234737B5Q46911300-50EBDE97-BC67-43FF-A466-B43A5AD882C2Q54996510-CC5E0052-EF90-492B-BFE2-0DD21EC4F9E3Q58776633-C89E5BE6-978B-4C3D-A488-31606B7305B2
P2860
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A novel genome-wide in vivo sc ...... ay modulators TMED3 and SOX12.
@ast
A novel genome-wide in vivo sc ...... ay modulators TMED3 and SOX12.
@en
type
label
A novel genome-wide in vivo sc ...... ay modulators TMED3 and SOX12.
@ast
A novel genome-wide in vivo sc ...... ay modulators TMED3 and SOX12.
@en
prefLabel
A novel genome-wide in vivo sc ...... ay modulators TMED3 and SOX12.
@ast
A novel genome-wide in vivo sc ...... ay modulators TMED3 and SOX12.
@en
P2093
P2860
P356
P1476
A novel genome-wide in vivo sc ...... ay modulators TMED3 and SOX12.
@en
P2093
Alice Melotti
Ariel Ruiz i Altaba
Arnaud Duquet
Arwen Conod
Chandan Seth
Monica Malerba
Sonakshi Mishra
P2860
P304
P356
10.15252/EMMM.201303799
P577
2014-06-11T00:00:00Z